Yelak Biru/LinkedIn
Apr 19, 2025, 08:17
Yelak Biru: UK grants first approval for Blenrep in multiple myeloma
Yelak Biru, President and Chief Executive Officer at International Myeloma Foundation, shared a post on X:
“UK grants first approval for Blenrep in multiple myeloma:
Dr. Joseph Mikhael, highlighted the importance of accessible combination therapies like Blenrep in community settings where many patients are treated, noting their potential to extend remission and survival.”
Rakesh Popat, Associate Professor at shared this post on X, adding:
“MHRA first to approve Bela Vd and Bela Pd for relapsed myeloma.
UK myeloma docs: remember to enrol into the ProMMise trial of Bela-Vd so we can build the evidence to remove ocular examinations.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 19, 2025, 10:37
Apr 19, 2025, 09:38